VP Business Development at Evotec for contract API, drug product, preclinical development and integrated INDiGO IND packages inclusive of all three.
You've done lead optimization to find the right compound. You have demonstrated potency, selectivity and efficacy. There's just one problem. It isn't soluble enough to develop - you won't be able to achieve necessary concentrations in your tox studies and the formulation isn't suitable for the clinic. Please join us for a webinar where our experts present a real case study of developing a rescue formulation using minimal amounts of API.
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explain how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z4NDn0 #bioavailability #preformulation #earlyformulation #drugdevelopment